Literature DB >> 20634295

Uremic cardiomyopathy and insulin resistance: a critical role for akt?

David Semple1, Katie Smith, Sunil Bhandari, Anne-Marie L Seymour.   

Abstract

Uremic cardiomyopathy is a classic complication of chronic renal failure whose cause is unclear and treatment remains disappointing. Insulin resistance is an independent predictor of cardiovascular mortality in chronic renal failure. Underlying insulin resistance are defects in insulin signaling through the protein kinase, Akt. Akt acts as a nodal point in the control of both the metabolic and pleiotropic effects of insulin. Imbalance among these effects leads to cardiac hypertrophy, fibrosis, and apoptosis; less angiogenesis; metabolic remodeling; and altered calcium cycling, all key features of uremic cardiomyopathy. Here we consider the role of Akt in the development of uremic cardiomyopathy, drawing parallels from models of hypertrophic cardiac disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634295     DOI: 10.1681/ASN.2009090900

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

Review 1.  Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Authors:  Xiaoliang Wang; Jiang Liu; Christopher A Drummond; Joseph I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2017-04-03       Impact factor: 6.902

2.  Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD.

Authors:  Rafael Kramann; Johanna Erpenbeck; Rebekka K Schneider; Anna B Röhl; Marc Hein; Vincent M Brandenburg; Merel van Diepen; Friedo Dekker; Nicolaus Marx; Jürgen Floege; Michael Becker; Georg Schlieper
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

3.  Mitochondrial dysfunction in uremic cardiomyopathy.

Authors:  David Taylor; Sunil Bhandari; Anne-Marie L Seymour
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

4.  Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.

Authors:  Jian Xie; Joonho Yoon; Sung-Wan An; Makoto Kuro-o; Chou-Long Huang
Journal:  J Am Soc Nephrol       Date:  2014-12-04       Impact factor: 10.121

5.  Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation.

Authors:  Jason C Choi; Wei Wu; Antoine Muchir; Shinichi Iwata; Shunichi Homma; Howard J Worman
Journal:  J Biol Chem       Date:  2012-10-09       Impact factor: 5.157

6.  Maternal nutrient restriction predisposes ventricular remodeling in adult sheep offspring.

Authors:  Wei Ge; Nan Hu; Lindsey A George; Stephen P Ford; Peter W Nathanielsz; Xiao-Ming Wang; Jun Ren
Journal:  J Nutr Biochem       Date:  2013-01-17       Impact factor: 6.048

7.  mTOR-Independent autophagy inducer trehalose rescues against insulin resistance-induced myocardial contractile anomalies: Role of p38 MAPK and Foxo1.

Authors:  Qiurong Wang; Jun Ren
Journal:  Pharmacol Res       Date:  2016-06-27       Impact factor: 7.658

8.  Hydrogen sulfide alleviates cardiac contractile dysfunction in an Akt2-knockout murine model of insulin resistance: role of mitochondrial injury and apoptosis.

Authors:  Nan Hu; Maolong Dong; Jun Ren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-03-12       Impact factor: 3.619

9.  Association of systemic collagen type IV formation with survival among patients undergoing hemodialysis.

Authors:  Diana J Leeming; Morten A Karsdal; Lars M Rasmussen; Alexandra Scholze; Martin Tepel
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

Review 10.  Insulin resistance in patients with chronic kidney disease.

Authors:  Min-Tser Liao; Chih-Chien Sung; Kuo-Chin Hung; Chia-Chao Wu; Lan Lo; Kuo-Cheng Lu
Journal:  J Biomed Biotechnol       Date:  2012-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.